Data on epcoritamab with rituximab and lenalidomide, results on a novel oral CELMoD agent, and outcomes from late-line CAR T-cell therapy are among highlights in follicular lymphoma (FL) presented at ...

The FDA has granted accelerated approval for a subcutaneous (SC) formulation of mosunetuzumab (Lunsumio VELO, Roche) for the treatment of certain adults with relapsed or refractory follicular lymphoma ...

Cervical lymphadenopathy presents a shared anatomic challenge for clinicians, yet it serves as the divergent starting point ...

Bhopal (Madhya Pradesh): AIIMS Bhopal is set to expand its health infrastructure on a large scale this year, which will help patients get advanced treatment within the state. According to AIIMS ...

At the San Antonio Breast Cancer Symposium, Jennifer Specht, MD, of the University of Washington and Fred Hutch Cancer Center, Seattle, presented results from the ECOG-ACRIN FEATURE trial, a phase II ...

Bioluminescence images of untreated and treated mice with human B cell lymphoma. Optimal results occurred with 8.51 MBq of [177Lu]Lu-ofatumumab (bottom row). Ofa = ofatumumab. Images created by ...

A study by a Singapore government agency has found that children exposed to high levels of screen time before age two showed brain development changes linked to slower decision-making and higher ...